Abstract:BACKGROUND: An increase in cardiac work-load during hypertension promotes an adaptive response consisting of cardiomyocytes hypertro phy. Although this response is initially compensatory, continuing cardiac overload leads to a decreased global cardiac function and subsequently to heart failure, and among the mechanisms involved, that contributing to the progressive loss of cardiomyocytes has attracted more and more attention.OBJECTIVE: To explore the changes of the expressions of apoptosis regulating oncogene Bcl-2 and Bax in myocardial tissue during genetic hypertension and left ventricular hypertrophy, and evaluate the effect of valsartan, the antagonist to angiotensin Ⅱ type 1 receptor(AT1R) on the ratio of the Bcl-2/Bax.DESIGN: A randomized controlled study.SETTINGS: Cardiological department in a medical college of university anda university hospital.MATERIALS: The trial was completed in the Central Laboratory, People's Hospital of Peking University. Thirty spontaneously hypertensive rats(SHR)of 8 weeks old were divided into valsartan group and non-treated group according to the method of random number table, and another 15 Wistar rats of 8-week old were taken as the controls.INTERVENTIONS: All the rats were fed for 8 weeks, the left ventricular tissues were excised and weighed for later use. Part of the myocardial tissues were fixed in 100 mL/L buffered formalin for 6 hour, and were embedded by routine paraffin wax for morphological study. The cardiac index was calculated by cardiac mass/body mass. The expressions of apoptosis regulating Bcl-2 and Bax proteins were detected by immunohistochemistry and Western blot.MAIN OUTCOME MEASURES: Expressions of Bcl-2 and Bax protein as scanning band absorbance in Western blot, the ratio of Bcl-2/Bax.RESULTS: There was high expression of Bax protein in the myocardium of SHR, after valsartan treatment for 8 weeks, the expression of Bax protein in the myocardiun of SHR was significantly reduced to the level near to that in the control group. The expressions of Bcl-2 protein in the valsartan group and control group were insignificantly different from that in the non-treated group( P ＞ 0.05) . The ratios of bax/bcl-2 in the valsartan group(6.71± 1.10) and control group(5.86 ±0. 70) were obviously higher than that in the non-treated group(0. 63 ±0.23) ( P ＜ 0.05).CONCLUSION: Cardiac apoptosis is one of the possible mechanisms for compensatory myocardial hypertrophy developing into heart failure. Early valsartan treatment on hypertension has not only the effect of depression, but also can effectively inhibit myocardial apoptosis.

The study of expression of AGT in hypertensive rats model combined with myocardial hypertrophy

Expression of MKP-1 in myocardium of hypertensive rat at different ages and its effect on myocardial hypertrophy

Losartan Reduced Connexin43 Expression in Left Ventricular Myocardium of Spontaneously Hypertensive Rats

ERK Expression and Activation in Myocardial Hypertrophy of Spontaneously Hypertensive Rats with Different Ages

The Relationship of Left Ventricular Hypertrophy and Ang iotensin Ⅱ Receptor in Spontaneously Hypertensive Rats

Myocardial expression of Ets-1 and CTGF in spontaneously hypertensive rats and its relationship with cardiac remodeling

Effects of irbesartan on expression of connective tissue growth factor in myocardium of spontaneously hypertensive rats

Nanoparticle-mediated RNA interference of angiotensinogen decreases blood pressure and improves myocardial remodeling in spontaneously hypertensive rats

Variation of Serum Angiopoietin-2 in Renovascular Hypertensive Rats and Therapeutic Effect of Telmisartan

The relationship between hepatocyte growth factor and myocardial fibrosis in spontaneously hypertensive rats

Proteomic Analysis of Hypertrophied Left Ventricle in Spontaneously Hypertensive Rats

[Effect of Tanshinone II A on the Transforming Growth Factor Beta1/smads Signal Pathway in Rats with Hypertensive Myocardial Hypertrophy].

The Influence of Ectogenic Nitric Oxide Inhibitor and Accelerator on the Thickness of Cardiac Ventricle and Angiotensin Ⅱ of Myocardium in Hypertensive Rats

[Changes of Mitogen-Activated Protein Kinase Activity in Cardiac Tissues, Ang II and Cardiac Hypertrophy in Spontaneously Hypertensive Rats].

Expression and analysis of ACE and ACE2 in the kidney of spontaneously hypertensive rats

Effect of the Angiotensin II Receptor Blocker Valsartan on Cardiac Hypertrophy and Myocardial Histone Deacetylase Expression in Rats with Aortic Constriction

Role of the Alkylglycerone Phosphate Synthase in Isoproterenol-Induced Cardiac Hypertrophy

The significance of tumor necrosis factor-αand interleukin-6 in experiment of myocardium hypertrophy

ALTERATION OF FUNCTIONAL RECEPTORS IN HEART FOR HUMAN UROTENSIN II IN PRESSURE-OVERLOADINDUCED CARDIAC HYPERTROPHY RATS

Effect of Valsartan on the Expressions of Bcl-2 and Bax Proteins in Myocardium of Spontaneously Hypertensive Rats

Expression of Mitogen-Activated Protein Kinase in Hypertrophic Myocardium of Renal Hypertension Rats